imatinib mesylate has been researched along with Tricuspid Incompetence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akashi, K; Aoki, K; Aoki, T; Arita, T; Iwasaki, H; Kamimura, T; Kato, K; Matsushima, T; Minami, M; Miyamoto, T; Muta, T; Ogawa, R; Takenaka, K; Tanimoto, K; Yamasaki, S | 1 |
| Barst, RJ; Campbell, P; Peacock, A; Quinn, D; Rocha, GQ; Shah, AM; Solomon, SD | 1 |
1 trial(s) available for imatinib mesylate and Tricuspid Incompetence
| Article | Year |
|---|---|
Effect of imatinib as add-on therapy on echocardiographic measures of right ventricular function in patients with significant pulmonary arterial hypertension.
Topics: Analysis of Variance; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Echocardiography, Doppler; Exercise Tolerance; Female; Humans; Hypertension, Pulmonary; Hypertrophy, Left Ventricular; Imatinib Mesylate; Male; Middle Aged; Observer Variation; Stroke Volume; Tricuspid Valve Insufficiency; Vascular Resistance; Ventricular Dysfunction, Right | 2015 |
1 other study(ies) available for imatinib mesylate and Tricuspid Incompetence
| Article | Year |
|---|---|
Comparative analysis of pulmonary hypertension in patients treated with imatinib, nilotinib and dasatinib.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Dasatinib; Echocardiography; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Pyrimidines; Treatment Outcome; Tricuspid Valve Insufficiency; Young Adult | 2017 |